Biopharma Group Articles & Resources

June 13, 2023

Biopharma Group to launch new GMP freeze drying production facility

Opening in Quarter 4, 2023, Biopharma Group’s new GMP freeze drying facility is set to provide a much needed resource to pharmaceutical companies needing small batch production facilities for first-in-human trials. With construction having started in January of 2023, the new GMP facility in Winchester, UK, will provide freeze drying for up to 3,200 2R vials in their state-of-the-art VirTis S10 freeze dryer, along with full isolation facilities in a grade A cleanroom environment for sterile production of both liquid and lyophilised products.
May 23, 2023

When freeze drying cytotoxic samples, how do you ensure safety whilst maintaining product integrity?

Freeze drying pharma and diagnostic products is essential in the bioprocessing industry but compared to many other pharmaceuticals, freeze drying cytotoxic agents carries additional risk. How can we carry out lyophilisation of cytotoxic drugs while ensuring the safety of all involved?
April 27, 2023

Investment in Lyobeads – A Massive Step Forward for Lyo R&D

Biopharma Group has taken its extensive experience within the freeze drying industry to help increase lyophilization productivity, reduce costs and reduce cycle times by investing in its lyobead production capabilities. Biopharma Group’s lyobead generation line can create millions of lyobeads a month.
April 27, 2023

The importance of cycle parameters in lyophilisation & why one size does not fit all.

Freeze drying has become a popular technique across a variety of industries including, but not limited to diagnostics, pharmaceutical, biotech, and food to name a few, all of whom use freeze drying in the processing of their products in different ways.
August 18, 2022

Staff Spotlight – Dr Kevin Ward

At Biopharma Group we are aiming to highlight the incredible team we have and shine light on the key areas of there roles. Our latest staff spotlight is on our Director of Research & Development; Doctor Kevin Ward. We sat down with him to under stand his role in more detail and other interesting facts about him.
August 12, 2022

How & why to build a QbD process to optimise the efficiency of your freeze drying projects

Quality by design (QbD) for lyophilisation is about building a robust process that proactively flags critical points and ensures consistent delivery of the best quality product, not only by minimising risk but also through greater understanding of the process itself. Regulatory bodies such as the FDA require details of the lyophilisation cycle
August 12, 2022

How freeze drying optimises the processing and viability of collagen bio-scaffolds

Collagen bio-scaffolds are hugely beneficial to many medical fields and therefore it is essential that the process used to develop them is as robust and viable as possible. Here, Magdalena Witek, Research Scientist at Biopharma, provides an insight into the significance of efficient process optimisation and applications.
August 12, 2022

ADCs and BIOSIMILARS: The development towards a new generation of targeted therapies

Antibodies-based therapeutics are perhaps the most successful and versatile drug approach developed in the last 30 years. They not only have found application as vaccines and drug carriers but have also been applied to analytical methods such as ELISA (Enzyme-linked Immunosorbent Assay), Wester blotting and flow cytometry.